These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35509841)

  • 1. Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia via the KLF2-Mediated Mechanism.
    Wang X; Huo R; Liang Z; Xu C; Chen T; Lin J; Li L; Lin W; Pan B; Fu X; Chen S
    Oxid Med Cell Longev; 2022; 2022():8336070. PubMed ID: 35509841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating NLRP3 Inflammasome-Induced Pyroptosis via Nrf2: TBHQ Limits Hyperoxia-Induced Lung Injury in a Mouse Model of Bronchopulmonary Dysplasia.
    Wang M; Zhang F; Ning X; Wu C; Zhou Y; Gou Z; Fan Y; Duan R; Li Z; Shao C; Lu L
    Inflammation; 2023 Dec; 46(6):2386-2401. PubMed ID: 37556072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine prevents hyperoxia-induced lung injury in neonatal mice through NLRP3 inflammasome and NF-κB pathway.
    Chen S; Wu Q; Zhong D; Li C; Du L
    Respir Res; 2020 Jun; 21(1):140. PubMed ID: 32513156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse.
    Chen D; Zhao HM; Deng XH; Li SP; Zhou MH; Wu YX; Tong Y; Yu RQ; Pang QF
    Exp Lung Res; 2024; 50(1):25-41. PubMed ID: 38419581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant CXCL17 Treatment Alleviates Hyperoxia-Induced Lung Apoptosis and Inflammation In Vivo and Vitro by Activating the AKT Pathway: A Possible Therapeutic Approach for Bronchopulmonary Dysplasia.
    Chen P; Cheng Y; Hu J; Fang R; Yang LQ
    Mol Biotechnol; 2024 Sep; 66(9):2349-2361. PubMed ID: 37710083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effects of 18β-Glycyrrhetinic Acid on Neonatal Rats with Hyperoxia Exposure.
    Qing C; Ziyun L; Xuefei Y; Xinyi Z; Xindong X; Jianhua F
    Inflammation; 2022 Jun; 45(3):1224-1238. PubMed ID: 34989920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia.
    Liao J; Kapadia VS; Brown LS; Cheong N; Longoria C; Mija D; Ramgopal M; Mirpuri J; McCurnin DC; Savani RC
    Nat Commun; 2015 Nov; 6():8977. PubMed ID: 26611836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin attenuates the hyperoxic lung injury in neonatal mice: Implications for Bronchopulmonary dysplasia (BPD).
    Maturu P; Wei-Liang Y; Androutsopoulos VP; Jiang W; Wang L; Tsatsakis AM; Couroucli XI
    Food Chem Toxicol; 2018 Apr; 114():23-33. PubMed ID: 29432836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine's protective mechanism against hyperoxic injury in neonatal rats.
    Zhang QY; Feng Y; Cai H
    J Physiol Pharmacol; 2024 Jun; 75(3):. PubMed ID: 39042394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant CCN1 prevents hyperoxia-induced lung injury in neonatal rats.
    Vaidya R; Zambrano R; Hummler JK; Luo S; Duncan MR; Young K; Lau LF; Wu S
    Pediatr Res; 2017 Nov; 82(5):863-871. PubMed ID: 28700567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM-1 Attenuates RIPK3-mediated Necroptosis in Hyperoxia-induced Lung Injury in Neonatal Mice.
    Syed MA; Shah D; Das P; Andersson S; Pryhuber G; Bhandari V
    Am J Respir Cell Mol Biol; 2019 Mar; 60(3):308-322. PubMed ID: 30281332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of PVT1 Enhances YTHDC1-Mediated m6A Modification of IL-33 in Hyperoxia-Induced Lung Injury During Bronchopulmonary Dysplasia.
    Bao T; Liu X; Hu J; Ma M; Li J; Cao L; Yu B; Cheng H; Zhao S; Tian Z
    Inflammation; 2024 Apr; 47(2):469-482. PubMed ID: 37917328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway.
    Wu Q; Chong L; Shao Y; Chen S; Li C
    Int Immunopharmacol; 2019 Aug; 73():414-423. PubMed ID: 31152979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genipin attenuates hyperoxia-induced lung injury and pulmonary hypertension via targeting glycogen synthase kinase-3 β in neonatal rats.
    Li J; Shi J; Li P; Guo X; Wang T; Liu A
    Nutrition; 2019 Jan; 57():237-244. PubMed ID: 30196116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats].
    Wang XL; Xue XD
    Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):446-51. PubMed ID: 19951473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with Geranylgeranylacetone Induces Heat Shock Protein 70 and Attenuates Neonatal Hyperoxic Lung Injury in a Model of Bronchopulmonary Dysplasia.
    Tokuriki S; Igarashi A; Okuno T; Ohta G; Naiki H; Ohshima Y
    Lung; 2017 Aug; 195(4):469-476. PubMed ID: 28447205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperoxia-mediated transcriptional activation of cytochrome P4501A1 (CYP1A1) and decreased susceptibility to oxygen-mediated lung injury in newborn mice.
    Jiang W; Maturu P; Liang YW; Wang L; Lingappan K; Couroucli X
    Biochem Biophys Res Commun; 2018 Jan; 495(1):408-413. PubMed ID: 29101037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of resveratrol on hyperoxia-induced lung injury in neonatal rats.
    Özdemir ÖM; Gözkeser E; Bir F; Yenisey Ç
    Pediatr Neonatol; 2014 Oct; 55(5):352-7. PubMed ID: 24630815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis.
    Yang M; Chen Y; Huang X; Shen F; Meng Y
    Lung; 2023 Aug; 201(4):425-441. PubMed ID: 37490064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of hyperoxic acute lung injury by Lycium barbarum polysaccharide via inhibiting NLRP3 inflammasome.
    Hong CY; Zhang HD; Liu XY; Xu Y
    Arch Pharm Res; 2019 Oct; 42(10):902-908. PubMed ID: 31388826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.